申请人:HEALTH RESEARCH, INC.
公开号:US20160024083A1
公开(公告)日:2016-01-28
Provided are carbazole and carbazole-like compounds (e.g., pyridoindole and pyrrolodipyridine) compounds, that can be used to selectively kill cancer cells, specifically androgen-receptor expressing prostate cancer cells. Also provided is a method of treating AR-positive prostate cancer in a subject diagnosed with or suspected of having AR positive or negative cancer, comprising administering an effective amount of a carbazole and carbazole-like compound to said subject.
提供的是各种类似于咔唑的化合物(如吡啶吲哚和吡咯二吡啶化合物),可以用于有选择性地杀死癌细胞,特别是表达雄激素受体的前列腺癌细胞。同时,还提供了一种治疗AR阳性前列腺癌的方法,包括向被诊断为或怀疑患有AR阳性或阴性癌症的患者施用有效量的咔唑和类咔唑化合物。